Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

English Court of Appeal finds in favor of Teva on Copaxone(R) patent litigation and upholds validity of Copaxone patent until May 2015
Fingolimod modulates microglial activation to augment markers of remyelination.
Asymptomatic lung disease caused by Mycobacterium kansasii as an opportunistic infection in a patient treated with natalizumab for relapsing-remitting multiple sclerosis.
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases.
Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis.
Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis.
Positive year one results from Biogen Idec's Phase 3 advance trial of PLEGRIDY™ (peginterferon beta-1a) presented at AAN meeting
Early relapses, onset of progression, and late outcome in multiple sclerosis.
Identification of the LDL Receptor-Related Protein-1 Interactome in Central Nervous System myelin suggests a role in the clearance of necrotic cell debris.
White matter astrocytes in health and disease.
Demyelination affects temporal aspects of perception: An optic neuritis study.
Identification of Selective Inhibitors of the Potassium Channel Kv1.1-1.2((3)) by High-Throughput Virtual Screening and Automated Patch Clamp.
Fatigue, depression and sleep disturbances in Iranian patients with multiple sclerosis.
[The influence of locomotor treatment using robotic body-weight-supported treadmill training on rehabilitation outcome of patients suffering from neurological disorders].
2nd Annual Congress on Neurology and Epidemiology
The Brief Repeatable Battery: psychometrics and normative values with age, education and gender corrections in a Serbian population.
The delta-subunit of the epithelial sodium channel (ENaC) enhances channel activity and alters proteolytic ENaC activation.
Amiloride HCl
Vitamin D-dependent rickets, HLA-DRB1, and the risk of multiple sclerosis.
Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis.
Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally.
Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
SIRT1 deacetylates RORγt and enhances Th17 cell generation.
Laquinimod suppress antigen presentation in relapsing-remitting multiple sclerosis: in-vitro high-throughput gene expression study.

Pages